Storia in 4 fonti

Moderna Borrows $2 Billion To Expand Oncology Business - Moderna (NASDAQ:MRNA)

Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth and strategically manage debt.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo2 g fa

Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth and strategically manage debt.

The biotech company will sell notes due 2032, with an option to raise an additional $300 million, days after its stock hit a multi-year high